Pakistan Addressing Lack Of Research

16 June 1996

Pakistan's government will address the issue of the lack of indigenous research in the medical and pharmaceutical industries, said an assistant to the country's Prime Minister, Benazir Bhutto. Reported in the Pakistan Times, the assistant noted that the first step has already been taken with the recent establishment of a close working relationship between the Ministry of Health and the Pakistan Medical Research Council.

An amount equal to around $1.2 million will be collected from profit-making pharmaceutical companies for the setting-up of pharmaceutical research projects, while the MoH has already started utilizing funds for three drug research projects.

The Pakistan government is to spend 2.36 billion crore ($682.0 million) this year on primary health care programs. The government is also implementing a radical preventive health program, as well as child immunization campaigns against malaria and hepatitis A and B.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight